More than 700 people worldwide have been diagnosed with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The U.S. Food and Drug Administration (FDA) believes that women with textured breast implants have a small but increased risk of developing this uncommon cancer. In this episode, Mark Clemens, M.D., plastic surgeon at The University of Texas MD Anderson Cancer Center and one of the world’s leading experts, discusses BIA-ALCL treatment and prophylactic removal of breast implants.

The information and material provided during this podcast are just recommendations. There are other medically appropriate options available that are not addressed in this podcast, and every provider must exercise independent medical judgment to determine what is medically appropriate and best practice based on each individual patient’s medical needs. As a listener of this podcast, you agree to release from liability and hold harmless UT MD Anderson, its agencies, officers, and employees for any accident, injury, illness, death, loss, or damage arising from or relating to, directly or indirectly, this podcast.

Podden och tillhörande omslagsbild på den här sidan tillhör MD Anderson Cancer Center. Innehållet i podden är skapat av MD Anderson Cancer Center och inte av, eller tillsammans med, Poddtoppen.